Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia

NCT00733655 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2023-09-28

No results posted yet for this study

Summary

In this study the investigators will obtain histological samples from people with hereditary haemorrhagic telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome).

Conditions

  • Telangiectasia, Hereditary Hemorrhagic

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Claire L Shovlin · Imperial College London

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00733655 on ClinicalTrials.gov